Sponsored by:

Nuclear Medicine: Page 244

SPECT/CT may reduce lymphedema risk in breast cancer patients
By Cynthia E. Keen
The risk of radiation-induced damage to critical drainage lymph nodes during treatment for breast cancer may be reduced by using SPECT/CT during treatment planning, according to findings presented at this month's San Antonio Breast Cancer Symposium.
December 12, 2010
Neoprobe schedules FDA meeting
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe will meet with the U.S. Food and Drug Administration in the first quarter of 2010 to discuss its plans to begin clinical testing of its RIGScan cancer-detecting technology.
December 9, 2010
Siemens wins U.K. SPECT contract
By AuntMinnie.com staff writers
Siemens Healthcare said it has won an installation of its Symbia S dual-head SPECT system at a U.K. hospital system.
December 8, 2010
Lantheus, Siemens invited to QCEIP
By AuntMinnie.com staff writers
Lantheus Medical Imaging, Siemens Healthcare's Diagnostics division, and Baxter International have been selected to participate in the QUEST Comparative Effectiveness and Innovation Program (QCEIP).
December 7, 2010
PET/CT helps predict lung cancer recurrence
By AuntMinnie.com staff writers
PET/CT scans are a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation, according to a study published in the December issue of the Journal of Nuclear Medicine.
December 7, 2010
IBA Molecular gets good news on Dopacis
By AuntMinnie.com staff writers
Radiopharmaceutical developer IBA Molecular has taken another step toward clearance to market its radiopharmaceutical product Dopacis (F-18 fluorodopa) in 12 member states of the European Union.
December 7, 2010
Lantheus begins using LEU Mo-99 targets
By AuntMinnie.com staff writers
Lantheus Medical Imaging has begun commercial production of its TechneLite technetium-99m generators using molybdenum-99 (Mo-99) produced with low-enriched uranium (LEU) targets.
December 6, 2010
GE partners with Janssen
By AuntMinnie.com staff writers
GE Healthcare is collaborating with Janssen Pharmaceutica to identify a biosignature related to Alzheimer's disease.
December 5, 2010
Nordion to divest MDS Nordion Belgium operations
By AuntMinnie.com staff writers
Nordion announced it has signed a nonbinding letter of agreement with Best Medical International of Springfield, VA, for the divestiture of the Fleurus, Belgium, operations of MDS Nordion of Ottawa, Ontario.
December 1, 2010
FDG-PET shows prowess in PTLD diagnosis and management
By Wayne Forrest
CHICAGO - FDG-PET/CT is useful in the early diagnosis, follow-up, and management of post-transplant lymphoproliferative disease (PTLD), according to a University of Nebraska study presented Wednesday at the 2010 RSNA conference.
November 30, 2010
2010 12 01 14 11 21 569 Zahiri Ptld Thumb
GE debuts 3T MRI magnet, MBI scanner, PET/CT MRI, wireless DR
By Brian Casey and Wayne Forrest
CHICAGO - A new 3-tesla MRI magnet, a molecular breast imaging (MBI) system, a hybrid PET/CT MR suite, and a wireless digital radiography (DR) detector are among the highlights in the booth of GE Healthcare at this week's RSNA meeting.
November 29, 2010
2010 11 30 11 51 56 151 Ge Flashpad 200
Mirada adds Oncology Fusion to Vitrea Enterprise Suite
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical announced its Oncology Fusion XD3 multimodality image fusion analysis package is now available as a fully integrated option with the Vitrea Enterprise Suite from advanced visualization firm Vital Images.
November 28, 2010
Previous Page
Page 244 of 440
Next Page